Efficacy of ISST in Schizophrenia
Schizophrenia
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring social cognition, social skills, cognitive remediation, functional outcome, treatment adherence
Eligibility Criteria
Inclusion Criteria:
- Written informed consent
- DSM-IV-TR diagnosis of schizophrenia (295.10-30, 295.90)
- PANSS at baseline: total score ≤ 75
- Proficiency in German language.
Exclusion Criteria:
- Lack of accountability
- Positive urine drug-screening for illicit drugs at screening (except cannabinoids and benzodiazepines)
- Serious suicidal risk at screening visit
- Other relevant axis 1-diagnoses according to diagnostic interview (MINI);
- Other relevant neurological or somatic disorders
- Verbal IQ<80 (MWT-B)
Sites / Locations
- Rheinhessen-Fachklinik Alzey
- Vivantes Klinikum Am Urban
- Dept. of Psychiatry and Psychotherapy, University of Bonn
- Dept. of Psychiatry and Psychotherapy, University of Cologne
- Dept. of Psychiatry and Psychotherapy, University of Düsseldorf
- Dept. of Psychiatry and Psychotherapy, University of Tübingen
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Integrated Social Cognitive and Behavioral Skills Therapy
Neurocognitive Remediation Therapy
The Integrated Social Cognitive and Behavioral Skills Therapy (ISST) shall target expressive and interactional behavior skills together with those social cognitive domains (facial and prosodic affect recognition, social perception, theory-of-mind) known to be most impaired (Savla, 2012) and most closely associated with functional outcome (Fett, 2012) in schizophrenia.
The Neurocognitive Remediation Therapy (NCRT) shall target impairments in attention, memory, and executive functions as an active comparator to the ISST.